| Esmya (ulipristal acetate) / ASKA Pharma, Gedeon Richter, AbbVie, Perrigo Company |
NCT00041899: Comparison of Blood Levels of Two Formulations of the Selective Hormone Receptor Modulator CDB-2914 |
|
|
| Completed | 1 | 15 | US | CDB-2914, COB-2914 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Healthy | | 03/05 | | |
NCT01493791: CDB-2914 for Abnormal Uterine Bleeding in Premenopausal Women |
|
|
| Withdrawn | 1 | 0 | NA | CDB-2914 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Urogenital Abnormalities | 07/13 | 07/13 | | |
NCT02634437: Study of Ulipristal Acetate in Female Patients With Moderately or Severely Impaired Renal Function, Compared With Matched Healthy Female Subjects |
|
|
| Completed | 1 | 19 | US | Ulipristal acetate | Allergan | Renal Function | 12/16 | 12/16 | | |
NCT03156127: A Study to Compare the Pharmacokinetics and Safety/Tolerability of BR-UPS (Ulipristal Acetate) 5 mg Tablet With Inisia (Ulipristal Acetate) 5 mg Tablet |
|
|
| Withdrawn | 1 | 0 | RoW | BR-UPS 5 mg tablet, Inisia 5 mg tablet | Boryung Pharmaceutical Co., Ltd | Uterine Myoma | 07/17 | 10/17 | | |
NCT03230539: A proof-of Concept, Randomized 3-month Study to Evaluate the Effects of Three Contraceptive Intrauterine Systems Delivering Copper and a Daily Dose of 5, 20 or 40 μg of Ulipristal Acetate (UPA) |
|
|
| Unknown status | 1 | 30 | RoW | Ulipristal Acetate IUS delivering Cu and 5μg, Ulipristal Acetate IUS delivering Cu and 20μg, Ulipristal Acetate IUS delivering Cu and 40μg | Population Council | Contraception | 01/18 | 05/18 | | |
NCT03342859: Mode of Action Study of Vilaprisan and Ulipristal Acetate in Patients With Uterine Fibroids for Whom Surgery is Planned |
|
|
| Terminated | 1 | 10 | Europe | Vilaprisan, BAY1002670, Ulipristal | Bayer | Leiomyoma | 12/18 | 01/20 | | |
NCT03354117: On Demand Contraception: Ulipristal Acetate Plus a COX-2 Inhibitor at Peak Fertility |
|
|
| Completed | 1 | 12 | US | Ulipristal Acetate 30 MG Oral Tablet, Meloxicam | Stanford University | Contraception | 05/19 | 05/19 | | |
NCT02922127: Compare Daily Ulipristal Acetate and Combined Oral Contraceptive Effects on Breast Epithelial Cell Proliferation |
|
|
| Completed | 1 | 29 | US | Ulipristal Acetate, Ella, Combined Oral Contraceptive Pill, Portia | Columbia University, Weill Medical College of Cornell University, Memorial Sloan Kettering Cancer Center | Contraception | 10/19 | 10/19 | | |
NCT03027973: Quality of Life Outcomes for Ulipristal Acetate and Tranexamic Acid in the Management of Heavy Menstrual Bleeding |
|
|
| Withdrawn | 1 | 0 | Canada | UPA, Ulipristal Acetate, TEA, Tranexamic Acid, Placebo (for UPA), Placebo (for TEA) | University of Saskatchewan | Heavy Menstrual Bleeding | 01/20 | 01/20 | | |
| Completed | 1 | 13 | US | Ulipristal Acetate | Stanford University | Termination of Pregnancy | 04/20 | 04/20 | | |
| Completed | 1 | 40 | US | ENG implant, Nexplanon, oral ulipristal acetate, Ella | University of Utah, Merck Sharp & Dohme LLC | Contraception | 10/22 | 01/24 | | |
